With over 20 years of experience in customer sales, service and success, Leanne brings a practical, human-centred perspective to digital transformation in insurance. She has spent the past six years with the Staysure group organisation, leading digital customer service teams across the UK and Sri Lanka and now designing conversational AI experiences that simplify complex processes and better meet customer needs.
Combining frontline and leadership experience, Leanne understands both customer expectations and operational challenges. This informs her approach to creating AI-driven interactions that are efficient, empathetic, and trustworthy.
Leanne’s work focuses on improving customer outcomes, streamlining service delivery, and ensuring conversational AI delivers meaningful business value.
Piers Bishop is Regional Vice President of Sales at Seismic, leading go-to-market strategy for EMEA Financial Services. He works with leading insurance and financial services organisations to harness AI-driven sales enablement — helping firms empower their advisors, strengthen client relationships, and deliver compliant, personalised experiences at scale.
Kimberly Prabhu is a clinical research and quality professional with deep experience across global clinical programmes in oncology, rare diseases, ophthalmology, and radiopharmaceuticals, spanning Phase I through IV. She specialises in inspection readiness (FDA, EMA, MHRA, Health Canada, TGA) and quality systems oversight, including GCP compliance, TMF management, risk-based monitoring, and CAPA oversight. Certified as CCRP and CCRA, Kimberly has led cross-functional teams as a VP/Director-level clinical leader. She is President and Founder of KRP Scientific Inc. and serves as US Clinical Quality Partner for The QARP Academy.
Evgen Levenko is a PhD in Medical Sciences, a cardiologist. His career in clinical research started over 30 years ago. He has experience in project management, planning, and oversight across more than 150 Phase I–III trials. Before joining the ARENSIA team, he worked at a number of international contract research organizations. In his current role as Country Manager, he oversees all aspects of ARENSIA’s clinical trials at the research centers across Ukraine (Kyiv and Ivano-Frankivsk clinics). Evgen is a focused and effective manager with strong leadership and professional skills. He oversaw the establishment of ARENSIA’s new research center in Kyiv, which is now ARENSIA’s largest research clinic. Under Evgen’s leadership, ARENSIA in Ukraine has become the fastest-growing branch of the international company.
PhD in Physics with a background in MRI research at a cancer hospital, followed by a Master’s in Medical Physics focused on quality control in imaging and radiotherapy. In 2010, I moved to the private sector as Quality and Regulatory Affairs Manager at IBA. Since then, I have held various roles in Regulatory and QA at IBA, Philips, and for nearly five years at QbD. This experience has enabled collaboration with competent authorities and notified bodies worldwide. I now support clients in defining effective regulatory strategies for medical device market access in Europe, the US, and Asia.
Dan Stephens is a Fellow on the Boston Scientific Global Advocacy Team. Dan completed his doctoral degree in cardiovascular physiology at the University of Texas Health Science Center San Antonio. He has twenty-five years of experience in the implantable medical device industry. As a part of the Advocacy Team, Dan is focused on real-world evidence, clinical trial policy, and patient science.
Dan’s work in RWE began in 2003 with retrospective analysis of clinical trial datasets collected during IDE studies of implantable devices. He has designed and executed projects that included outcomes data for heart failure patients, ablation procedure efficacy, and cardioversion success. He is involved in several regulatory collaborative community working groups focused on clinical data policy and strategy including AdvaMed Trade Association’s Clinical Trials, Medical Device Epidemiological Network Advancing Access to Representative Clinical Data, and Medical Device Innovation Consortium working groups.
Dan has authored articles on integrative physiology, cardiac device performance, clinical trial operations and recently joined scientists from Boston Scientific and Johnson & Johnson to author a textbook on Real-World Evidence in the medical device ecosystem; Leveraging Global Healthcare Data for Real-World Insights and Evidence Generation. His latest publications focus on the importance of regulatory science in creating data sets that are representative of the intended use population.
